Pm. Lavoie et al., SELECTIVE BINDING OF BACTERIAL TOXINS TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-EXPRESSING CELLS IS CONTROLLED BY INVARIANT CHAIN AND HLA-DM, Proceedings of the National Academy of Sciences of the United Statesof America, 94(13), 1997, pp. 6892-6897
Bacterial superantigens (Sr-fgs) bind to major histocompatibility comp
lex (MHC) class II molecules and activate T cells in a V beta-restrict
ed fashion. We recently identified subsets of HLA-DR1 molecules that s
how selectivity for SAgs. Here, we extend these observations Sv showin
g that different cell lineages demonstrate distinct SAg-binding specif
icities although they: all express HLA-DR1. Indeed, If cells bind stap
hylococcal enterotoxin A (SEA) and toxic shock syndrome toxin 1 (TSST-
1) with high affinity while staphylococcal enterotoxin B (SEE) binding
is barely detectable, In contrast, DR1-transfected HeLa cells show ef
ficient binding of SEE, but not of SEA or TSST-1. We investigated the
class II maturation events required for efficient interaction with SAg
s and found that the ability of cells to bind and present the toxins c
an be drastically modulated by coexpression of the class II-associated
invariant chain (Ii) and HLA-DM. SEA binding to DBI molecules require
d coexpression of Ii, whereas TSST-1 binding was selectively enhanced
by RI, Binding of SEE was affected by cell type-specific factors other
than Ii or DM. The selectivity of SAgs for different MNC class II pop
ulations was minimally affected by HLA-DR intrinsic polymorphism and c
ould not be explained by binding to alternative sites on DR molecules,
Our results indicate that SAgs are sensitive to structural heterogene
ity in class II molecules, which is consequent to the differential reg
ulation of expression of antigen processing cofactors. Therefore, me s
peculate that Staphylococcus aureus have retained the ability to expre
ss numerous SAgs in adaptation to the microheterogeneity displayed by
MHC class II molecules and that this may relate to their ability to in
fect different tissues.